| Primary |
| Hiv Infection |
68.3% |
| Convulsion Prophylaxis |
8.2% |
| Drug Use For Unknown Indication |
4.5% |
| Antiretroviral Therapy |
4.1% |
| Acquired Immunodeficiency Syndrome |
3.3% |
| Gastritis |
1.6% |
| Infection Prophylaxis |
1.6% |
| Product Used For Unknown Indication |
1.6% |
| Tuberculosis |
1.6% |
| Diarrhoea |
1.2% |
| Systemic Antiviral Treatment |
1.2% |
| Bronchiectasis |
0.4% |
| Diabetes Mellitus |
0.4% |
| Gastrointestinal Stromal Tumour |
0.4% |
| Hyperuricaemia |
0.4% |
| Prophylaxis |
0.4% |
| Raynaud's Phenomenon |
0.4% |
|
| Death |
32.1% |
| Drug Hypersensitivity |
10.7% |
| Pyrexia |
10.7% |
| Myocardial Infarction |
8.9% |
| Lymphadenopathy |
3.6% |
| Progressive Multifocal Leukoencephalopathy |
3.6% |
| Rash Maculo-papular |
3.6% |
| Vasculitis |
3.6% |
| Weight Decreased |
3.6% |
| Acute Coronary Syndrome |
1.8% |
| Anuria |
1.8% |
| Cerebrovascular Accident |
1.8% |
| Cholestasis |
1.8% |
| Colitis |
1.8% |
| Fall |
1.8% |
| Hepatic Cirrhosis |
1.8% |
| Hepatic Steatosis |
1.8% |
| Hepatitis B |
1.8% |
| Immune Reconstitution Syndrome |
1.8% |
| Loss Of Consciousness |
1.8% |
|
| Secondary |
| Hiv Infection |
67.4% |
| Drug Use For Unknown Indication |
9.9% |
| Antiretroviral Therapy |
4.4% |
| Hepatitis C |
2.4% |
| Pneumocystis Jiroveci Infection |
1.6% |
| Antifungal Prophylaxis |
1.5% |
| Mycobacterium Avium Complex Infection |
1.3% |
| Schizophrenia |
1.3% |
| Product Used For Unknown Indication |
1.2% |
| Prophylaxis Against Transplant Rejection |
1.2% |
| Acquired Immunodeficiency Syndrome |
1.0% |
| Hypertension |
1.0% |
| Prophylaxis |
1.0% |
| Drug Exposure During Pregnancy |
0.8% |
| Haemorrhage |
0.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.8% |
| Diabetes Mellitus |
0.7% |
| Cytomegalovirus Infection |
0.7% |
| Opportunistic Infection Prophylaxis |
0.6% |
| Acute Hiv Infection |
0.6% |
|
| Progressive External Ophthalmoplegia |
18.8% |
| Vomiting |
11.1% |
| Immune Reconstitution Syndrome |
7.7% |
| Lymphoma |
7.2% |
| Weight Decreased |
6.3% |
| Parkinsonism |
5.8% |
| Visual Disturbance |
4.8% |
| Subarachnoid Haemorrhage |
4.3% |
| Nausea |
3.4% |
| Osteonecrosis |
3.4% |
| Pregnancy |
3.4% |
| Small For Dates Baby |
3.4% |
| Urinary Tract Infection |
3.4% |
| Ophthalmoplegia |
2.9% |
| Transplant Rejection |
2.9% |
| Visual Impairment |
2.9% |
| Weight Increased |
2.4% |
| Renal Failure Acute |
1.9% |
| Renal Impairment |
1.9% |
| Urine Colour Abnormal |
1.9% |
|
| Concomitant |
| Hiv Infection |
62.8% |
| Drug Use For Unknown Indication |
13.7% |
| Prophylaxis |
2.8% |
| Acquired Immunodeficiency Syndrome |
2.6% |
| Antibiotic Prophylaxis |
2.6% |
| Tuberculosis |
1.8% |
| Product Used For Unknown Indication |
1.6% |
| Hiv Test Positive |
1.5% |
| Mycobacterium Avium Complex Infection |
1.3% |
| Antifungal Prophylaxis |
1.2% |
| Convulsion Prophylaxis |
1.1% |
| Infection Prophylaxis |
1.0% |
| Antiretroviral Therapy |
0.9% |
| Liver Disorder |
0.9% |
| Cytomegalovirus Viraemia |
0.8% |
| Diabetes Mellitus |
0.7% |
| Hypertension |
0.7% |
| Candidiasis |
0.6% |
| Coronary Artery Disease |
0.6% |
| Factor Viii Deficiency |
0.6% |
|
| Vomiting |
10.3% |
| Renal Failure |
8.0% |
| Renal Failure Acute |
6.9% |
| Weight Decreased |
6.9% |
| Pulmonary Embolism |
5.7% |
| Renal Tubular Necrosis |
5.7% |
| Transfusion Reaction |
5.7% |
| Ventricular Arrhythmia |
5.7% |
| White Blood Cell Count Decreased |
5.7% |
| Electrocardiogram Qt Prolonged |
4.6% |
| Death |
3.4% |
| Drug Toxicity |
3.4% |
| Gastroenteritis |
3.4% |
| General Physical Health Deterioration |
3.4% |
| Haemorrhage |
3.4% |
| Hepatic Function Abnormal |
3.4% |
| Hyperlipidaemia |
3.4% |
| Nodular Regenerative Hyperplasia |
3.4% |
| Palpitations |
3.4% |
| Pneumonia |
3.4% |
|
| Interacting |
| Hiv Infection |
58.3% |
| Blood Cholesterol Increased |
16.7% |
| Herpes Simplex |
8.3% |
| Phytotherapy |
8.3% |
| Weight Decreased |
8.3% |
|
| Red Blood Cell Count Abnormal |
50.0% |
| Vomiting |
50.0% |
|
